The pooled HR with fixed effect model was 1.51 (95% CI: 1.31–1.72; I2 = 0%; P = 0.48) (Figure 3), indicating high COX-2 expression significantly predicts poor OS of patients with breast cancer. Here, PTGS2 is linked to breast cancer.